BTIG Research Lowers DocGo (NASDAQ:DCGO) Price Target to $11.00

DocGo (NASDAQ:DCGO) had its price objective cut by stock analysts at BTIG Research from $13.00 to $11.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price target suggests a potential upside of 227.87% from the company’s previous close.

DCGO has been the topic of a number of other research reports. Stifel Nicolaus dropped their price target on shares of DocGo from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Friday, February 23rd. Needham & Company LLC dropped their target price on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. Canaccord Genuity Group dropped their target price on shares of DocGo from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. Finally, Cantor Fitzgerald dropped their target price on shares of DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a research report on Thursday, February 29th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, DocGo has a consensus rating of “Buy” and a consensus price target of $10.83.

DocGo Stock Performance

Shares of NASDAQ DCGO opened at $3.36 on Wednesday. The company has a market capitalization of $349.49 million, a P/E ratio of 47.93, a price-to-earnings-growth ratio of 0.37 and a beta of 0.91. DocGo has a 52-week low of $2.78 and a 52-week high of $10.82. The company’s 50 day moving average price is $3.74 and its 200-day moving average price is $4.71.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). The firm had revenue of $199.25 million during the quarter, compared to analyst estimates of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. Analysts forecast that DocGo will post 0.36 earnings per share for the current year.

Insider Activity at DocGo

In other DocGo news, Director Michael J. Burdiek acquired 10,000 shares of the stock in a transaction on Thursday, March 14th. The shares were purchased at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the completion of the acquisition, the director now owns 571,595 shares in the company, valued at approximately $2,063,457.95. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. 13.78% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. The Manufacturers Life Insurance Company raised its holdings in DocGo by 3.7% during the fourth quarter. The Manufacturers Life Insurance Company now owns 31,603 shares of the company’s stock worth $223,000 after buying an additional 1,135 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in DocGo by 8.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,617 shares of the company’s stock worth $136,000 after buying an additional 1,174 shares during the last quarter. Legal & General Group Plc raised its holdings in DocGo by 4.1% during the fourth quarter. Legal & General Group Plc now owns 33,116 shares of the company’s stock worth $234,000 after buying an additional 1,303 shares during the last quarter. Victory Capital Management Inc. raised its holdings in DocGo by 6.3% during the fourth quarter. Victory Capital Management Inc. now owns 22,010 shares of the company’s stock worth $220,000 after buying an additional 1,312 shares during the last quarter. Finally, Arizona State Retirement System raised its holdings in DocGo by 8.3% during the third quarter. Arizona State Retirement System now owns 26,516 shares of the company’s stock worth $141,000 after buying an additional 2,042 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.